CD69 and neoplasm: When focusing on TCF-1+PD-1+ subset (i.e., stem-like tumor-reactive CD8+ T cells), we could clearly detect the expression of TRM markers CD103 and CD69 in all samples, including non-metastatic TDLNs (Fig. 10c lower row and 10d).